A healthy volunteer in Seattle is the first person in the U.S. to receive a dose of an experimental coronavirus vaccine as part of a new clinical trial, government health officials announced today (March 16).
Over the next six weeks, researchers plan to enroll 45 participants in the trial, which will test the safety of the vaccine as well as its ability to induce an immune response in the volunteers. The trial will take place at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle.